Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested negative for COVID starting day 5 after first testing positive (And completing Paxlovid regimen), but then on day 9 had relapse in symptoms and began testing positive for COVID on rapid tests for another 3 days.; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested negative for COVID starting day 5 after first testing positive (And completing Paxlovid regimen), but then on day 9 had relapse in symptoms and began testing positive for COVID on rapid tests for another 3 days.) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment.    The patient's past medical history included COVID-19. Concomitant products included ERENUMAB AOOE (AIMOVIG [ERENUMAB AOOE]) for an unknown indication.   On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 27-Mar-2022, the patient experienced COVID-19 (Tested negative for COVID starting day 5 after first testing positive (And completing Paxlovid regimen), but then on day 9 had relapse in symptoms and began testing positive for COVID on rapid tests for another 3 days.). On 01-Apr-2022, COVID-19 (Tested negative for COVID starting day 5 after first testing positive (And completing Paxlovid regimen), but then on day 9 had relapse in symptoms and began testing positive for COVID on rapid tests for another 3 days.) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: testing positive for covid on rapid tests (Positive) Testing positive for COVID on rapid tests.         The patient taking other medications or products within 2 weeks of staring COVID-19 treatment but unaware of the name. The patient also previously received a unknown COVID-19 vaccine. The patient was tested negative for COVID starting day 5 after first testing positive (And completing Paxlovid regimen), but then on day 9 had relapse in symptoms and began testing positive for COVID on rapid tests for another 3 days. The device date 29-Apr-2022   No treatment drug details was reported. Company comment: This spontaneous case concerns a 33-year-old, male patient with past   medical history of COVID-19, who experienced the unexpected non-serious ADR event of COVID-19 (Tested negative for COVID starting day 5 after first testing positive (And completing Paxlovid regimen), which occurred 4 months 22 days after the third dose of mRNA-1273.  SARS-CoV-2 test was positive for covid on rapid tests as on unknown date. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a 33-year-old, male patient with past   medical history of COVID-19, who experienced the unexpected nonserious ADR event of COVID-19 (Tested negative for COVID starting day 5 after first testing positive (And completing Paxlovid regimen), which occurred 4 months 22 days after the third dose of mRNA-1273.  SARS-CoV-2 test was positive for covid on rapid tests as on unknown date. The benefit-risk relationship of mRNA-1273 is not affected by this report.